April 4, 2025

CAC 2000 Limited (CAC)
Unaudited financials for the first quarter ended January 31, 2025:

CAC 2000 Limited (CAC) reported an 11% decrease in turnover for the first quarter that ended January 31, 2025, totaling $190.36 million compared to $213.07 million in the corresponding three months last year.

The cost of sales amounted to $140.58 million (2024: $131.42 million), an increase of 7% year over year. Consequently, gross profit decreased by 39% to $49.78 million compared to $81.64 million for the first quarter ending January 31, 2024.

Selling & Distribution decreased by 44% to close at $4.42 million (2024: $7.95 million), while General Administration increased by 17% from $75.38 million in 2024 to $88.03 million for the three months. As a result, Total Expenses for the first quarter amounted to $92.45 million, an 11% increase relative to the $83.33 million reported in 2024.

Operating loss for the three months amounted to $42.56 million, a 5656% increase relative to a loss of $739,396 reported in 2024. Net finance cost totaled $16.05 million, a 50% increase from last year’s period (2024: $10.71 million).

Loss before taxation for the first quarter ended January 31, 2025, amounted to $58.61 million, a 412% decrease relative to a loss of $11.45 million reported in 2024.

No taxation was recorded for the three months (2024: $1.05 million). The net loss for the three months amounted to $58.61 million, a 369% decrease from the loss of $12.50 million reported in 2024.

Consequently, Loss Per Share for the three months amounted to $0.45 (2024: LPS: $0.10). The twelve-month trailing LPS was $0.18, and the number of shares used in these calculations was 129,032,258. Notably, CAC’s stock price closed the trading period on April 03, 2025, for $1.98.

Balance Sheet Highlights
The company’s assets totaled $1.33 billion (2024: $1.36 billion).

Shareholder’s equity was $306.22 million (2024: $330.08 million), representing a book value per share of $2.37 (2024: $2.56).

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.